Projects per year
Abstract
Marine invertebrate-associated symbiotic bacteria produce a plethora of novel secondary metabolites which may be structurally unique with interesting pharmacological properties. Selection of strains usually relies on literature searching, genetic screening and bioactivity results, often without considering the chemical novelty and abundance of secondary metabolites being produced by the microorganism until the time-consuming bioassay-guided isolation stages. To fast track the selection process, metabolomic tools were used to aid strain selection by investigating differences in the chemical profiles of 77 bacterial extracts isolated from cold water marine invertebrates from Orkney, Scotland using liquid chromatography-high resolution mass spectrometry (LC-HRMS) and nuclear magnetic resonance (NMR) spectroscopy. Following mass spectrometric analysis and dereplication using an Excel macro developed in-house, principal component analysis (PCA) was employed to differentiate the bacterial strains based on their chemical profiles. NMR 1H and correlation spectroscopy (COSY) were also employed to obtain a chemical fingerprint of each bacterial strain and to confirm the presence of functional groups and spin systems. These results were then combined with taxonomic identification and bioassay screening data to identify three bacterial strains, namely Bacillus sp. 4117, Rhodococcus sp. ZS402 and Vibrio splendidus strain LGP32, to prioritize for scale-up based on their chemically interesting secondary metabolomes, established through dereplication and interesting bioactivities, determined from bioassay screening.
Original language | English |
---|---|
Pages (from-to) | 3416-3448 |
Number of pages | 33 |
Journal | Marine Drugs |
Volume | 12 |
Issue number | 6 |
DOIs | |
Publication status | Published - 5 Jun 2014 |
Keywords
- metabolomics
- dereplication
- symbiotic bacteria
- mass spectrometry
- NMR
- multivariate analysis
- metabolic profiling
Fingerprint
Dive into the research topics of 'Metabolomic tools for secondary metabolite discovery from marine microbial symbionts'. Together they form a unique fingerprint.Profiles
-
Ruangelie Edrada-Ebel
- Strathclyde Institute Of Pharmacy And Biomedical Sciences - Senior Lecturer
Person: Academic
Projects
- 2 Finished
-
Potential novel antibiotics from microorganisms of under explored extreme marine habitats
25/07/16 → 24/09/16
Project: Research - Studentship
-
SBT: SeaBioTech
McNeil, B., Edrada-Ebel, R., Harvey, L. & Harvey, A.
European Commission - FP7 - Cooperation only
1/08/12 → 30/09/16
Project: Research
-
The re-emergence of natural products for drug discovery in the genomics era
Harvey, A., Edrada-Ebel, R. & Quinn, R. J., 23 Jan 2015, In: Nature Reviews Drug Discovery . 14, p. 111–129 19 p.Research output: Contribution to journal › Literature review › peer-review
Open AccessFile1932 Citations (Scopus)1099 Downloads (Pure) -
SeaBioTech: from sea-bed to test-bed : harvesting the potential of marine biodiversity for industrial biotechnology
MacIntyre, L., Zhang, T., Viegelmann, C. V., Cheng, C., Perrocco, D., Dowdells, C., Hentschel-Humeida, U., Abdelmohsen, U. R., Martinez, I. J., Moss, O. & Edrada-Ebel, R., Sept 2013.Research output: Contribution to conference › Poster › peer-review
-
Metabolomics identifies the building blocks of pharmacologically active metabolites in marine invertebrates and its microbial symbionts
Edrada-Ebel, R., Jul 2010, p. P3A-004. 1 p.Research output: Contribution to conference › Poster › peer-review